Iselin, NJ (PRWEB) November 12, 2014
Advanstar Pharmaceutical & Science Group (“Pharm/Sci Group”) announced today an expanded suite of content marketing products designed to extend client reach, raise the value and credibility of branded content and enhance the website audience experience. Advanstar Pharma/Sci established a new digital platform from which its clients can communicate a seamless integrated message to over a million viewers across multiple channels, using the most comprehensive database in the pharma/life science market, C.A.S.T.™.
Advanstar's Pharmaceutical/Science Group is the leading provider in a diversity of functional areas and content delivery vehicles across multiple markets within the pharmaceutical enterprise. The Group covers the pharma/biopharm/life science industries’ value chain through multiple brands and marketing channels, including ten leading business-to-business publications and websites. They are Applied Clinical Trials, BioPharm International, LCGC-North America, LCGC-Europe, LCGC-Asia Pacific, LCGC’s CHROMacademy, Pharmaceutical Executive, Pharmaceutical Technology, Pharmaceutical Technology-Europe and Spectroscopy.
"The science and pharmaceutical industries we serve have become increasingly complex," says Dave Esola, Vice President and General Manager of Advanstar's Pharmaceutical/Science Group. "In pharmaceuticals, it's no longer just the pill that's being branded, it's everything around the pill—education, prevention, services, disease. Our advertising clients want custom content products to be able to accommodate that complexity and to have the space to tell their brand's story."
Advanstar's Pharm/Sci Group already has in place a multi-platform approach to delivering credible branded advertising. From print to online to mobile to in-person events, Advanstar Pharm/Sci employs a custom-blended approach to successfully deliver a client's message to a targeted, qualified audience.
The new enhancements include additional programs and sophisticated and complementary groupings of digital and print custom offerings, revamped websites and a new digital platform.
"Recently," says Esola, "an executive at a firm approached our sales team wanting the opportunity to tell his brand's story. He didn't just want to say his brand was better than anyone else's. He also wanted to talk about the industry and to convey strategic information that could be shared within the analytical science community served by his company."
Esola said the executive chose to participate as a thought-leader in a Q&A Dedicated Dialogue, one of the Group's content marketing programs available in all of the Pharm/Sci magazines, appear on the website along with a branded video about his company and a white paper about his products, stressing their differential in the marketplace that a team of Pharm/Sci editors wrote and sent out to a targeted audience.
"In the end," says Esola, "the executive felt he’d covered all his bases, reaching his entire, highly diversified audience and effectively delivering his brand's story. In doing so, he also believed he’d made a valuable contribution as a thought-leader to the larger conversation in his field."
The Pharm/Sci Group’s new enhanced programs are about better tailoring the client's message to improve the full customer experience.
"Our clients and their customers consume and share information across multiple channels and devices. It's vital for us to offer one-of-a kind, digital products and to be out ahead of the pack. This is what our clients expect. We are a group of experts serving experts in the science and pharmaceutical world," says Esola.
About Advanstar Pharmacutical/Science Group
Advanstar's Pharmaceutical/Science Group is the leading information provider across multiple markets and functional areas within the pharmaceutical and science enterprise. We offer a 360 approach to communicating messages to a qualified audience. The community of more than 250,000 professionals represents the various functional units from research to market within the life science industry.